670 related articles for article (PubMed ID: 9743372)
1. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types.
Liu L; Ridefelt P; Håkansson L; Venge P
J Immunol; 1999 Nov; 163(10):5649-55. PubMed ID: 10553095
[TBL] [Abstract][Full Text] [Related]
3. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
4. Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species.
Carolan EJ; Casale TB
J Immunol; 1990 Oct; 145(8):2561-5. PubMed ID: 2170519
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
Erger RA; Casale TB
Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
[TBL] [Abstract][Full Text] [Related]
7. Priming of eosinophil migration across lung epithelial cell monolayers and upregulation of CD11b/CD18 are elicited by extracellular Ca2+.
Liu L; Hakansson L; Ridefelt P; Garcia RC; Venge P
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):713-21. PubMed ID: 12760968
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
9. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptides modulate human eosinophil chemotaxis.
Numao T; Agrawal DK
J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
12. PAF-induced eosinophil chemotaxis increases during an asthmatic attack and is inhibited by prednisolone in vivo and in vitro.
Shindo K; Koide K; Fukumura M
Biochem Biophys Res Commun; 1997 Aug; 237(1):146-51. PubMed ID: 9266847
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
14. Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells.
Yuan Q; Campanella GS; Colvin RA; Hamilos DL; Jones KJ; Mathew A; Means TK; Luster AD
Eur J Immunol; 2006 Oct; 36(10):2700-14. PubMed ID: 16983721
[TBL] [Abstract][Full Text] [Related]
15. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.
Kishimoto S; Shimadzu W; Izumi T; Shimizu T; Fukuda T; Makino S; Sugiura T; Waku K
J Immunol; 1996 Nov; 157(9):4126-32. PubMed ID: 8892648
[TBL] [Abstract][Full Text] [Related]
16. Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction.
Liu L; Mul FP; Lutter R; Roos D; Knol EF
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):771-80. PubMed ID: 8969272
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice.
Klein A; Pinho V; Alessandrini AL; Shimizu T; Ishii S; Teixeira MM
Br J Pharmacol; 2002 Mar; 135(5):1213-8. PubMed ID: 11877329
[TBL] [Abstract][Full Text] [Related]
19. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation.
Tsunoda H; Sakuma Y; Shirato M; Obaishi H; Harada K; Yamada K; Shimomura N; Machida Y; Yamatsu I; Katayama K
Arzneimittelforschung; 1991 Mar; 41(3):224-7. PubMed ID: 1867658
[TBL] [Abstract][Full Text] [Related]
20. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
